Market Access Jobs in Menlo Park, CA
Please select the country where you want to search for a job.
-
Job Type
-
Posting Date
5 Jobs Found | Sort By : Relevance | Posted Date
Less results matching your search!
Try removing some of the filters to get more results
No results matching your search!
Try removing some of the filters to get more results
Senior Manager, Procurement & Vendor Management (c...
Summit Therapeutics Sub
Menlo Park - USA
About Summit:Ivonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a single molecule. Ivonescimab displays unique cooperati...
Senior Managerassociate Director, Portfolio Strate...
Summit Therapeutics Sub
Menlo Park - USA
Location: Menlo Park CA Princeton NJ or Miami FL onsiteAbout Summit:Ivonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a...
Executive Director, Biostatistics
Summit Therapeutics Sub
Menlo Park - USA
About Summit:Ivonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a single molecule. Ivonescimab displays unique cooperati...
Credit Solutions Analyst - Growth & Middle Market ...
Mufg Bank
Menlo Park - USA
Do you want your voice heard and your actions to count Discover your opportunity with Mitsubishi UFJ Financial Group (MUFG) one of the worlds leading financial groups. Across the globe were 150000 colleagues striving to make a difference for every client organization and community we serve. We stand...
Director, Portfolio Strategy & Market Research
Summit Therapeutics Sub
Menlo Park - USA
About Summit: Ivonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a single molecule. Ivonescimab displays unique cooperat...
